These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32669888)

  • 1. Counterfeit drugs and medical devices in developing countries.
    Glass BD
    Res Rep Trop Med; 2014; 5():11-22. PubMed ID: 32669888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.
    Tadeg H; Berhane Y
    East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Counterfeit medicines--Japan and the world].
    Sato D
    Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on counterfeit antibiotics worldwide; public health risks.
    Delepierre A; Gayot A; Carpentier A
    Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substandard and counterfeit medicines: a systematic review of the literature.
    Almuzaini T; Choonara I; Sammons H
    BMJ Open; 2013 Aug; 3(8):e002923. PubMed ID: 23955188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Counterfeit medicines: a growing threat].
    Barbereau S
    Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Counterfeit drugs as a gobal threat to health].
    Golocorbin Kon S; Mikov M
    Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The health and economic effects of counterfeit drugs.
    Blackstone EA; Fuhr JP; Pociask S
    Am Health Drug Benefits; 2014 Jun; 7(4):216-24. PubMed ID: 25126373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterfeit pharmaceuticals: current status and future projections.
    Wertheimer AI; Chaney NM; Santella T
    J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.
    Mackey TK; Liang BA
    BMC Med; 2013 Oct; 11():233. PubMed ID: 24228892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we doing enough to prevent poor-quality antimalarial medicines in the developing world?
    Walker EJ; Peterson GM; Grech J; Paragalli E; Thomas J
    BMC Public Health; 2018 May; 18(1):630. PubMed ID: 29764407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I (Don't) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines.
    Ofori-Parku SS; Park SE
    BMC Public Health; 2022 Jun; 22(1):1094. PubMed ID: 35650557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of antiretroviral, antimalarial and antituberculosis medicines in Zambia: Findings of routine post-marketing surveillance.
    Jere E; Munkombwe D; Mukosha M; Mudenda S; Kalungia AC; Chabalenge B
    J Med Access; 2024; 8():27550834241266755. PubMed ID: 39071988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling Counterfeit Drugs: The Challenges and Possibilities.
    Pathak R; Gaur V; Sankrityayan H; Gogtay J
    Pharmaceut Med; 2023 Jul; 37(4):281-290. PubMed ID: 37188891
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.